Literature DB >> 16077415

Decellularization reduces the immune response to aortic valve allografts in the rat.

Steven R Meyer1, Jeevan Nagendran, Leena S Desai, Gina R Rayat, Thomas A Churchill, Colin C Anderson, Ray V Rajotte, Jonathan R T Lakey, David B Ross.   

Abstract

OBJECTIVES: Cryopreserved valve allografts used in congenital cardiac surgery are associated with a significant cellular and humoral immune response. This might be reduced by removal of antigenic cellular elements (decellularization). The aim of this study was to determine the immunologic effect of decellularization in a rat allograft valve model.
METHODS: Brown Norway and Lewis rat aortic valves were decellularized with a series of hypotonic and hypertonic buffers, protease inhibitors, gentle detergents (Triton X-100), and phosphate-buffered saline. Valves were implanted into Lewis rats in syngeneic and allogeneic combinations. Cellular (CD3 and CD8) infiltrates were assessed with morphometric analysis, and the humoral response was assessed with flow cytometry.
RESULTS: Morphometric analysis identified a significant reduction in CD3 + cell infiltrates (cells per square millimeter of leaflet tissue) in decellularized allografts compared with that seen in nondecellularized allografts at 1 (79 +/- 29 vs 3310 +/- 223, P < .001), 2 (26 +/- 11 vs 109 +/- 20, P = .004), and 4 weeks (283 +/- 122 vs 984 +/- 145, P < .001). Anti-CD8 staining confirmed the majority of infiltrates were cytotoxic T cells. Flow cytometric mean channel fluorescence intensity identified a negative shift (abrogated antibody formation) for decellularized allografts compared with nondecellularized allografts at 2 (19 +/- 1 vs 27 +/- 3, P = .033), 4 (35 +/- 2 vs 133 +/- 29, P = .001), and 16 weeks (28 +/- 2 vs 166 +/- 54, P = .017).
CONCLUSIONS: Decellularization significantly reduces the cellular and humoral immune response to allograft tissue. This could prolong the durability of valve allografts and might prevent immunologic sensitization of allograft recipients.

Entities:  

Mesh:

Year:  2005        PMID: 16077415     DOI: 10.1016/j.jtcvs.2005.03.021

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  18 in total

Review 1.  Tissue Engineering and Regenerative Medicine 2015: A Year in Review.

Authors:  Holly Wobma; Gordana Vunjak-Novakovic
Journal:  Tissue Eng Part B Rev       Date:  2016-02-23       Impact factor: 6.389

2.  Novel utilization of serum in tissue decellularization.

Authors:  Liqiong Gui; Stephen A Chan; Christopher K Breuer; Laura E Niklason
Journal:  Tissue Eng Part C Methods       Date:  2010-04       Impact factor: 3.056

3.  Mass transfer trends occurring in engineered ex vivo tissue scaffolds.

Authors:  Marc Moore; Malisa Sarntinoranont; Peter McFetridge
Journal:  J Biomed Mater Res A       Date:  2012-05-24       Impact factor: 4.396

Review 4.  Decellularized matrices for cardiovascular tissue engineering.

Authors:  Francesco Moroni; Teodelinda Mirabella
Journal:  Am J Stem Cells       Date:  2014-03-13

5.  Modification of human cancellous bone using Thai silk fibroin and gelatin for enhanced osteoconductive potential.

Authors:  Rungnapa Vorrapakdee; Sorada Kanokpanont; Juthamas Ratanavaraporn; Saranatra Waikakul; Chris Charoenlap; Siriporn Damrongsakkul
Journal:  J Mater Sci Mater Med       Date:  2012-12-08       Impact factor: 3.896

6.  CD133 antibody conjugation to decellularized human heart valves intended for circulating cell capture.

Authors:  John D Vossler; Young Min Ju; J Koudy Williams; Steven Goldstein; James Hamlin; Sang Jin Lee; James J Yoo; Anthony Atala
Journal:  Biomed Mater       Date:  2015-09-03       Impact factor: 3.715

7.  Extraction techniques for the decellularization of tissue engineered articular cartilage constructs.

Authors:  Benjamin D Elder; Sriram V Eleswarapu; Kyriacos A Athanasiou
Journal:  Biomaterials       Date:  2009-04-23       Impact factor: 12.479

8.  Development of decellularized human umbilical arteries as small-diameter vascular grafts.

Authors:  Liqiong Gui; Akihito Muto; Stephen A Chan; Christopher K Breuer; Laura E Niklason
Journal:  Tissue Eng Part A       Date:  2009-09       Impact factor: 3.845

Review 9.  Antigen removal for the production of biomechanically functional, xenogeneic tissue grafts.

Authors:  Derek D Cissell; Jerry C Hu; Leigh G Griffiths; Kyriacos A Athanasiou
Journal:  J Biomech       Date:  2013-11-08       Impact factor: 2.712

10.  Xenograft Failure of Pulmonary Valved Conduit Cross-linked with Glutaraldehyde or Not Cross-linked in a Pig to Goat Implantation Model.

Authors:  Dong Jin Kim; Yong Jin Kim; Woong-Han Kim; Soo-Hwan Kim
Journal:  Korean J Thorac Cardiovasc Surg       Date:  2012-10-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.